Literature DB >> 18071740

The value of vision.

Christine Knauer1, Norbert Pfeiffer.   

Abstract

BACKGROUND: The value of vision is assumed to be very high. To verify this assumption and to assign resources in medical care accordingly, it is necessary to quantify the value of vision. Although the value of vision is difficult to measure, visual quality of life can be quantified as a surrogate criterion. The measured value gains even more relevance if a comparison can be made between visual quality of life and systemic diseases. Multidisciplinary comparisons are only possible by using utility analysis. Two established methods to measure utility values are the standard gamble method and the time trade-off method. The purpose of this review is to find ophthalmologic utility values, and utility values affected by systemic diseases that correlate to the ophthalmologic ones.
METHODS: A literature search was conducted through PubMed of the National Library of Medicine ( http://www.ncbi.nlm.nih.gov ; date: 06.02.2006). The search terms were: "time trade-off / standard gamble" [text word] and "eye / vision / visual" [text word]; results 24. A report was classified as relevant if visually impaired persons were tested by the time trade-off method or the standard gamble method, or if information was provided on the reliability and validity of these measurements in a group of visually impaired persons. Additional searches were done to find associated publications. A total of 42 publications were found to be of interest.
RESULTS: Results showed that patients, with 20/30-20/50 visual acuity would be willing to pay 19% of their lifetime to get back normal visual acuity. Patients with 20/200-20/400 visual acuity would give up 48% of their lifetime, and blind people would give 60% of their lifetime to regain normal visual acuity. Comparable utility values are seen in patients with AIDS (21%), patients after a stroke who are unable to walk and wash themselves without assistance (46%), and bedridden and incontinent patients following a stroke (66%).
CONCLUSION: Patients attach great value to vision. The time trade-off method appears to be an appropriate tool to quantify visual quality of life, and one that can be used to compare utility values of different diseases.

Entities:  

Mesh:

Year:  2007        PMID: 18071740     DOI: 10.1007/s00417-007-0668-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  39 in total

1.  A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes.

Authors:  M M Brown; G C Brown; S Sharma; A F Smith; J Landy
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Utility values and age-related macular degeneration.

Authors:  G C Brown; S Sharma; M M Brown; J Kistler
Journal:  Arch Ophthalmol       Date:  2000-01

3.  Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons.

Authors:  C M Mangione; S Berry; K Spritzer; N K Janz; R Klein; C Owsley; P P Lee
Journal:  Arch Ophthalmol       Date:  1998-02

4.  A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma.

Authors:  R D Smith; J Hall; H Gurney; P R Harnett
Journal:  Med J Aust       Date:  1993-03-01       Impact factor: 7.738

Review 5.  [Blindness in Germany--today and in 2030].

Authors:  C Knauer; N Pfeiffer
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

6.  Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration.

Authors:  G C Brown; M M Brown; S Sharma
Journal:  Can J Ophthalmol       Date:  2000-04       Impact factor: 1.882

7.  Evidence-based medicine and cost-effectiveness.

Authors:  G C Brown; S Sharma; M M Brown; S Garrett
Journal:  J Health Care Finance       Date:  1999

8.  The VF-14. An index of functional impairment in patients with cataract.

Authors:  E P Steinberg; J M Tielsch; O D Schein; J C Javitt; P Sharkey; S D Cassard; M W Legro; M Diener-West; E B Bass; A M Damiano
Journal:  Arch Ophthalmol       Date:  1994-05

9.  Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning.

Authors:  J Tsevat; J G Solzan; K M Kuntz; J Ragland; J S Currier; R L Sell; M C Weinstein
Journal:  Med Care       Date:  1996-01       Impact factor: 2.983

10.  [Measuring patient's quality of life in ophthalmology].

Authors:  C Hirneiss; A S Neubauer; U Welge-Lüssen; K Eibl; A Kampik
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

View more
  4 in total

1.  Hospitalized eye injury in a Chinese urban population: a 7-year retrospective analysis.

Authors:  Min Wu; Jian Ye
Journal:  Int J Ophthalmol       Date:  2010-06-18       Impact factor: 1.779

2.  [Current possibilities of visual rehabilitation].

Authors:  S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2018-10       Impact factor: 1.059

Review 3.  Current methods of visual rehabilitation.

Authors:  Susanne Trauzettel-Klosinski
Journal:  Dtsch Arztebl Int       Date:  2011-12-26       Impact factor: 5.594

4.  [The influence of visual rehabilitation on secondary depressive disorders due to age-related macular degeneration. A randomized controlled pilot study].

Authors:  A Mielke; K Wirkus; R Niebler; G Eschweiler; N X Nguyen; S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.